Inhibitory Antibodies

抑制性抗体（Inhibitory Antibodies，常被称为中和抗体或阻断抗体）是一种能够特异性结合目标分子（如受体、酶或细胞因子），并直接抑制或阻断其正常生物学功能的特异性抗体。

货号 产品 反应 应用 偶联 引用
BF6150 Lirilumab Human FACS, ELISA, Functional assay Unconjugated 0
BF6151 Lumiliximab Human FACS, ELISA, Functional assay Unconjugated 0
BF6152 Mavrilimumab Human FACS, ELISA, Functional assay Unconjugated 0
BF6153 Mepolizumab Human FACS, ELISA, Functional assay Unconjugated 0
BF6154 Muromonab Human FACS, ELISA, Functional assay Unconjugated 0
BF6155 Nivolumab Human FACS, ELISA, Functional assay Unconjugated 0
BF6156 Olaratumab Human FACS, ELISA, Functional assay Unconjugated 0
BF6157 Otelixizumab Human FACS, ELISA, Functional assay Unconjugated 0
BF6158 Otlertuzumab Human FACS, ELISA, Functional assay Unconjugated 0
BF6159 Ozanezumab Human FACS, ELISA, Functional assay Unconjugated 0
BF6160 Parsatuzumab Human FACS, ELISA, Functional assay Unconjugated 0
BF6161 Pinatuzumab Human FACS, ELISA, Functional assay Unconjugated 0
BF6162 Ponezumab Human FACS, ELISA, Functional assay Unconjugated 0
BF6163 Radretumab Human FACS, ELISA, Functional assay Unconjugated 0
BF6164 Ranibizumab (anti-VEGF) Human FACS, ELISA, Functional assay Unconjugated 0
BF6165 Rilotumumab Human FACS, ELISA, Functional assay Unconjugated 0
BF6166 Seribantumab Human FACS, ELISA, Functional assay Unconjugated 0
BF6167 Siltuximab Human FACS, ELISA, Functional assay Unconjugated 0
BF6168 Simtuzumab Human FACS, ELISA, Functional assay Unconjugated 0
BF6169 Tabalumab Human FACS, ELISA, Functional assay Unconjugated 0
BF6170 Tanezumab Human FACS, ELISA, Functional assay Unconjugated 0
BF6171 Tildrakizumab Human FACS, ELISA, Functional assay Unconjugated 0
BF6172 Tovetumab Human FACS, ELISA, Functional assay Unconjugated 0
BF6173 Tralokinumab Human FACS, ELISA, Functional assay Unconjugated 0
BF6174 Visilizumab Human FACS, ELISA, Functional assay Unconjugated 0
BF6175 Zalutumumab Human FACS, ELISA, Functional assay Unconjugated 0
BF6176 Nipocalimab Human FACS, ELISA, Functional assay Unconjugated 0
BF6177 Sotigalimab Human FACS, ELISA, Functional assay Unconjugated 0
BF6178 Inclacumab Human FACS, ELISA, Functional assay Unconjugated 0
BF6179 Vesencumab Human FACS, ELISA, Functional assay Unconjugated 0
BF6180 Etrolizumab Human FACS, ELISA, Functional assay Unconjugated 0
BF6181 Obexelimab Human FACS, ELISA, Functional assay Unconjugated 0
BF6182 Iladatuzumab Human FACS, ELISA, Functional assay Unconjugated 0
BF6183 Levilimab Human FACS, ELISA, Functional assay Unconjugated 0
BF6184 Tabituximab Human FACS, ELISA, Functional assay Unconjugated 0
BF6185 Refanezumab Human FACS, ELISA, Functional assay Unconjugated 0
BF6186 Dectrekumab Human FACS, ELISA, Functional assay Unconjugated 0
BF6187 Cixutumumab Human FACS, ELISA, Functional assay Unconjugated 0
BF6188 Naratuximab Human FACS, ELISA, Functional assay Unconjugated 0
BF6189 NC-318 (5G-12) Human FACS, ELISA, Functional assay Unconjugated 0
BF6190 Tigatuzumab Human FACS, ELISA, Functional assay Unconjugated 0
BF6191 Anti-LIF Ab (MSC-1) Human FACS, ELISA, Functional assay Unconjugated 0
BF6192 Lirentelimab Human FACS, ELISA, Functional assay Unconjugated 0
BF6193 Nesvacumab Human FACS, ELISA, Functional assay Unconjugated 0
BF6194 NEO-201 Human FACS, ELISA, Functional assay Unconjugated 0
BF6195 IMAB027 Human FACS, ELISA, Functional assay Unconjugated 0
BF6196 Volagidemab Human FACS, ELISA, Functional assay Unconjugated 0
BF6197 KRN-330 Human FACS, ELISA, Functional assay Unconjugated 0
BF6198 Imsidolimab Human FACS, ELISA, Functional assay Unconjugated 0
BF6199 Lusvertikimab Human FACS, ELISA, Functional assay Unconjugated 0